Headline News

SAN DIEGO — Combination therapy with peginterferon alfa-2b and nucleos(t)ide analogues resulted in significantly higher hepatitis B surface antigen loss vs. monotherapy in children with HBV, especially among those aged younger than 7 years.

In this episode, host Shikha Jain, MD, speaks with Melody Harris about the evolution of precision medicine, what physicians and companies can do to help patients better understand precision oncology and more.

WASHINGTON — Increased reimbursement and expanded educational opportunities are two key solutions to the workforce shortage in adult and pediatric rheumatology, according to two speakers at ACR Convergence 2024.

Timing and type of treatment for older adults with early-stage breast cancer varied greatly by race, study results showed.

Patients with alcohol use disorder who used GLP-1 agonists to treat obesity or type 2 diabetes had a decreased risk for hospitalization due to alcohol use disorder, according to a study published in JAMA Psychology.

INDIANAPOLIS — An aceclidine-based miotic may improve both near and distance vision in presbyopic patients as a result of its pupil selectivity, according to research presented at Academy 2024.

NEW YORK — In this video from the Infectious Diseases in Children Symposium, David W. Kimberlin, MD, provides an overview of the topics that were added to the 2024-2027 Red Book published earlier this year.

ORLANDO — In this video from the AIMed24 Annual Meeting, Rubin Pillay, PhD, discusses trends in AI that may shape the future of health care.

SAN DIEGO — Patients with diabetes who were prescribed glucagon-like peptide-1 receptor agonists had lower odds of metabolic dysfunction-associated steatotic liver disease after liver transplantation, noted a presenter at The Liver Meeting.

WASHINGTON — The use of colchicine for gout flare prevention imparts a “modest” decrease in the risk for knee or hip replacement over several years, according to a study presented at ACR Convergence 2024.